| PERIOD ENDING | 3-Oct-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 1,353,960 | 1,209,150 | 1,195,107 | 1,419,264 | | Cost of Revenue | 1,259,630 | 1,133,390 | 1,126,517 | 1,335,466 | | | Gross Profit | 94,330 | 75,760 | 68,590 | 83,798 | | | Operating Expenses | | Research Development | 3,962 | 3,811 | 4,720 | 4,192 | | Selling General and Administrative | 60,263 | 57,889 | 57,055 | 62,987 | | Non Recurring | 21,312 | 14,135 | 18,958 | 13,033 | | Others | 1,072 | 1,072 | 1,023 | 1,650 | | | | Total Operating Expenses | 86,609 | 76,907 | 81,756 | 81,862 | | | | Operating Income or Loss | 7,721 | (1,147) | (13,166) | 1,936 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,150) | 3,469 | 6,752 | 4,003 | | Earnings Before Interest And Taxes | 2,571 | 2,322 | (6,414) | 5,939 | | Interest Expense | 30,302 | 29,391 | 28,112 | 29,183 | | Income Before Tax | (27,731) | (27,069) | (34,526) | (23,244) | | Income Tax Expense | 4,554 | 14,057 | 3,012 | 2,029 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (32,285) | (41,126) | (37,538) | (25,273) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,285) | (41,126) | (37,538) | (25,273) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,285) | ($41,126) | ($37,538) | ($25,273) |
|
0.02% Nasdaq 
0.33%
Income Statement
